Battle, MW, Ewing, SF, Dickson, C, Obaje, J, Edgeworth, KN, Bindbeutel, R, Antoniou-Kourounioti, RL, Nusinow, DA and Jones, ...

Dr. Roxana Redis: Retinal organoids have shown remarkable promise, especially in cases where traditional models fall short.

Here, we used deep full-length single-cell RNA-sequencing to distinguish post-mitotic cone and rod developmental states and cone-specific features that contribute to retinoblastomagenesis. The ...

Bees actually have five eyes: two compound eyes and three simple eyes, called ocelli. The two compound eyes are those huge ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the first closing ...

The FDA has extended the review period for the BLA for NT-501 in the treatment of macular telangiectasia type 2.

Brand new work from the laboratory of Michel Cayouette, Director of the Cellular Neurobiology Research Unit at the Montreal ...

11月15日，著名国际顶尖学术期刊《Cell》在线发表了深圳大学刘宏涛课题组题为“The Arabidopsis blue-light photoreceptor CRY2 is active in darkness to inhibit root growth”的研究论文。

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announced today that it awarded 35 new research grants totaling $19.8 ...

Significant vision protection in both standard and low light conditions, and protection of photoreceptor integrity in the central fovea, the region of the retina most important for activities such as ...

A research team from the University of Basel has succeeded in synthesizing simple, environmentally sensitive cells complete with artificial organelles. For the first time, the researchers have ...

a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and (v) RND1, a novel hypoimmune induced pluripotent stem cell line being ...